Major Accountabilities 1,Runs internal customer surveys to identify brand training needs 2,Responsible for developing a modular brand training course for new reps (orientation training), existing reps (refresh training in the region) or for new brands (launch brands). 3,Coordinates brand training sessions with Medical Team (Disease & Brand knowledge), Brand Team (Brand strategy, messages, material, PoA), FF training team (providing platform and brand selling training) and ensures best in class execution of rep training across the three teams. 4,Ensures high quality training material for brand training (MCC approval!) 5, Measures quality of brand training per rep (test) and provides brand certificates for successfully passed brand qualification 6,Monitors competitor training initiatives and shares with internal customers 7,Manages brand training budget Authorities 1,Leadership responsibility of reps during trainings 2,Proposes brand training plans to GBM, Marketing Director and Regional Director. 3, Proposes and manages brand training budget 4,Internal facilitation and coordination with all functions, specifically brand team., RDs, ASMs, PSMs and Medical Marketing.

企業介紹:
1996年，繼瑞士汽巴-嘉基公司和山德士公司全球完成合并之后，其在華制藥業務實施合并，成立了諾華在中國的第一家公司－－北京諾華制藥有限公司。 十幾年來，北京諾華取得了驕人的業績，業務遍及全國260多個城市，復合增長率超過20%。2006年公司銷售額達到了18億元人民幣。 諾華制藥在中國設立常用藥品事業部、抗感染藥品事業部、移植及中樞神經藥品事業部、眼科藥品事業部和腫瘤藥品事業部，實施區域化管理，建立了極具競爭力的產品組合。公司在心血管、內分泌、抗感染、腫瘤、移植免疫、風濕疼痛、骨代謝、眼科、中樞神經系統、皮科、及消化科等11大領域擁有30多種國際一流的高科技專利產品，相關產品的市場份額在血管緊張素轉換酶抑制劑領域排名第一，在血管緊張素拮抗劑領域排名第二，在移植領域排名第一，在腫瘤領域排名第一。